KRAS and cancer: However, while less than 1% of KRAS mutations reported in ICGC/COSMIC data are located at other codons, 13% (13/97), 22% (2/9), and 31% (6/19) of such mutations were detected in the plasma samples of cancer cases, chronic pancreatitis, and controls, respectively (Figure 2A).